Beauty Health Co/The reports that FMR LLC beneficially owned 17,183,231 shares of Class A common stock, representing 13.4% of the class as of 03/31/2026. The filing also discloses that the Fidelity Growth Company Commingled Pool held 8,073,663 shares or 6.3% of the Class A stock as of 03/31/2026. The Schedule 13G/A is signed by an authorized representative under a power of attorney dated April 13, 2026.
Positive
None.
Negative
None.
Insights
FMR LLC reports a 13.4% stake in Beauty Health Co/The, led by aggregated fund holdings.
FMR LLC's Schedule 13G/A lists 17,183,231 shares beneficially owned, with sole dispositive power shown. The disclosure signals an institutional passive ownership position reported under beneficial ownership rules.
Subsequent filings may clarify whether holdings change; cash‑flow treatment and disposition plans are not stated in this excerpt.
Filing structure and exhibits align with Schedule 13G/A practice and cite a power of attorney and Exhibit 99.
The form names a power of attorney effective April 13, 2026, and references Exhibit 99 for a 13d-1(k)(1) agreement. The disclosure follows beneficial‑owner reporting conventions for an institutional investor.
Investors should refer to the named exhibits for more details on allocation and subsidiary attribution.
Key Figures
FMR LLC beneficial ownership:17,183,231 sharesPercent of class:13.4%Fidelity Growth Company Pool holding:8,073,663 shares+2 more
5 metrics
FMR LLC beneficial ownership17,183,231 sharesas of 03/31/2026
Percent of class13.4%Class A common stock, as of 03/31/2026
Fidelity Growth Company Pool holding8,073,663 sharesas of 03/31/2026 (6.3% of Class A)
Sole voting power (FMR LLC)17,174,901 sharesreported on cover page
Sole dispositive power (FMR LLC)17,183,231 sharesreported on cover page
Key Terms
Schedule 13G/A, Beneficially owned, Power of attorney
3 terms
Schedule 13G/Aregulatory
"Amendment No. 8 to a Schedule 13G/A reporting beneficial ownership"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
Beneficially ownedfinancial
"Amount beneficially owned: 17183231.00"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Power of attorneylegal
"Duly authorized under Power of Attorney effective as of April 13, 2026"
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.
What stake does FMR LLC report in SKIN (Beauty Health Co/The)?
FMR LLC reports beneficial ownership of 17,183,231 shares, equal to 13.4% of Class A common stock as of 03/31/2026. The filing is a Schedule 13G/A reflecting institutional beneficial‑owner disclosure rather than a change‑of‑control filing.
Does the filing show any subsidiaries or other holders for SKIN ownership?
The filing references Exhibit 99 and describes ownership on behalf of investment vehicles. It names the Fidelity Growth Company Commingled Pool with 8,073,663 shares or 6.3% as of 03/31/2026, indicating holdings across related funds.
Who signed the Schedule 13G/A for SKIN and under what authority?
The Schedule 13G/A was signed by Richard Bourgelas as a duly authorized signatory for FMR LLC and Abigail P. Johnson under a power of attorney effective April 13, 2026, with signature dates of 05/05/2026 shown on the filing.
Does the filing state how FMR LLC exercises voting or dispositive power for SKIN shares?
The cover responses show FMR LLC with 17,174,901 sole voting power and 17,183,231 sole dispositive power. The Schedule 13G/A lists voting and dispositive counts, consistent with institutional reporting conventions.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 8)
BEAUTY HEALTH CO/THE
(Name of Issuer)
CLASS A COMMON STOCK
(Title of Class of Securities)
88331L108
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
88331L108
1
Names of Reporting Persons
FMR LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
17,174,901.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
17,183,231.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
17,183,231.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
13.4 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
CUSIP Number(s):
88331L108
1
Names of Reporting Persons
Abigail P. Johnson
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
17,183,231.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
17,183,231.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
13.4 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
BEAUTY HEALTH CO/THE
(b)
Address of issuer's principal executive offices:
2165 SPRING STREET,LONG BEACH,CA,USA,90806
Item 2.
(a)
Name of person filing:
FMR LLC
(b)
Address or principal business office or, if none, residence:
245 Summer Street, Boston, Massachusetts 02210
(c)
Citizenship:
Not applicable
(d)
Title of class of securities:
CLASS A COMMON STOCK
(e)
CUSIP No.:
88331L108
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
17183231.00
(b)
Percent of class:
13.4 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Please see the responses to Items 5 and 6 on the cover page.
(ii) Shared power to vote or to direct the vote:
0.00
(iii) Sole power to dispose or to direct the disposition of:
17183231.00
(iv) Shared power to dispose or to direct the disposition of:
0.00
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the CLASS A COMMON STOCK of BEAUTY HEALTH CO/THE. The interest of Fidelity Growth Company Commingled Pool, in the CLASS A COMMON STOCK of BEAUTY HEALTH CO/THE, amounted to 8073663.00 shares or 6.3% of the total outstanding CLASS A COMMON STOCK at 03/31/2026.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See attached Exhibit 99.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
FMR LLC
Signature:
Richard Bourgelas
Name/Title:
Duly authorized under Power of Attorney effective as of April 13, 2026, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:
05/05/2026
Abigail P. Johnson
Signature:
Richard Bourgelas
Name/Title:
Duly authorized under Power of Attorney effective as of April 13, 2026, by and on behalf of Abigail P. Johnson*
Date:
05/05/2026
Comments accompanying signature: *This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on April 29,2026, accession number: 0000315066-26-000738.
